DOI QR코드

DOI QR Code

Stereotactic Radiosurgery with the CyberKnife for Pituitary Adenomas

  • Cho, Chul-Bum (Catholic Neuroscience Center, Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea, College of Medicine) ;
  • Park, Hae-Kwan (Catholic Neuroscience Center, Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea, College of Medicine) ;
  • Joo, Won-Il (Catholic Neuroscience Center, Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea, College of Medicine) ;
  • Chough, Chung-Kee (Catholic Neuroscience Center, Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea, College of Medicine) ;
  • Lee, Kyung-Jin (Catholic Neuroscience Center, Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea, College of Medicine) ;
  • Rha, Hyoung-Kyun (Catholic Neuroscience Center, Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea, College of Medicine)
  • Published : 2009.03.28

Abstract

Objective : In recent years, CyberKnife has emerged as an important treatment modality in the management of pituitary adenomas. Treatment results after performing CyberKnife and the complications of this procedure are reviewed. Methods : Twenty-six patients with pituitary adenomas received stereotactic radiosurgery with the CyberKnife (CKRS). The follow-up periods ranged from 7 months to 47 months (mean$\pm$SD : $30{\pm}12.7$ months). The patients consisted of 17 with non-functioning adenomas, 3 with prolactinomas and 6 with acromegaly. The change in the tumor volume, visual acuity, hormonal function, and complications by this therapy were analyzed in each case. Results : The tumor control rate was 92.3%. Hormonal function was improved in all of the 9 (100%) functioning adenomas. Hormonal normalization was observed in 4 of the 9 (44%) patients with a mean duration of 16 months. In two patients (7.6%), visual acuity worsened due to cystic enlargement of the tumor after CKRS. No other complications were observed. Conclusion : CyberKnife is considered safe and effective in selected patients with pituitary adenomas. However, longer follow-up is required for a more complete assessment of late toxicity and treatment efficacy.

Keywords

References

  1. Adler JR, Gibbs IC, Puataweepong P, Chang SD : Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 59 : 244-254; discussion 244-254, 2006 https://doi.org/10.1227/01.NEU.0000223512.09115.3E
  2. Adler Jr JR, Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL : The Cyberknife : a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 69 : 124-128, 1997 https://doi.org/10.1159/000099863
  3. Arnott RD, Pestell RG, McKelvie PA, Henderson JK, McNeill PM, Alford FP : A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease : prediction of outcome. Acta Endocrinol (Copenh) 123 : 423-430, 1990
  4. Asa SL : Practical pituitary pathology : what does the pathologist need to know? Arch Pathol Lab Med 132 : 1231-1240, 2008
  5. Breen P, Flickinger JC, Kondziolka D, Martinez AJ : Radiotherapy for nonfunctional pituitary adenoma : analysis of long-term tumor control. J Neurosurg 89 : 933-938, 1998 https://doi.org/10.3171/jns.1998.89.6.0933
  6. Burch W : A survey of results with transsphenoidal surgery in Cushing's disease. N Engl J Med 308 : 103-104, 1983 https://doi.org/10.1056/NEJM198301133080216
  7. Chandler WF, Schteingart DE, Lloyd RV, McKeever PE, Ibarra-Perez G : Surgical treatment of Cushing's disease. J Neurosurg 66 : 204-212, 1987 https://doi.org/10.3171/jns.1987.66.2.0204
  8. Chang SD, Adler JR : Robotic and radiosurgery-the cyberknife. Stereotact Funct Neurosurg 76 : 204-208, 2001 https://doi.org/10.1159/000066719
  9. Chang SD, Gibbs IC, Sakamoto GT, Lee E, Oyelese A, Adler JR Jr : Staged stereotactic irradiation for acoustic neuroma. Neurosurgery 56 : 1254-1263, 2005 https://doi.org/10.1227/01.NEU.0000159650.79833.2B
  10. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J : The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68 : 860-866, 1991 https://doi.org/10.1002/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO;2-4
  11. Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, et al : The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336 : 172-177, 1997 https://doi.org/10.1056/NEJM199701163360303
  12. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al : The prevalence of pituitary adenomas : a systematic review. Cancer 101 : 613-619, 2004 https://doi.org/10.1002/cncr.20412
  13. Feigl GC, Bonelli CM, Berghold A, Mokry M : Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg (5 Suppl) 97 : 415-421, 2002
  14. Flickinger JC, Nelson PB, Martinez AJ, Deutsch M, Taylor F : Radiotherapy of nonfunctional adenomas of the pituitary gland. Cancer 63 : 2409-2414, 1989 https://doi.org/10.1002/1097-0142(19890615)63:12<2409::AID-CNCR2820631206>3.0.CO;2-M
  15. Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB Jr, et al : Repeat transsphenoidal surgery for Cushing's disease. J Neurosurg 71 : 520-527, 1989 https://doi.org/10.3171/jns.1989.71.4.0520
  16. Ganz JC, Backlund EO, Thorsen FA : The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact Funct Neurosurg (Suppl 1) 61 : 30-37, 1993 https://doi.org/10.1159/000100657
  17. Grigsby PW, Simpson JR, Fineberg B : Late regrowth of pituitary adenomas after irradiation and/or surgery : hazard function analysis. Cancer 63 : 1308-1312, 1989 https://doi.org/10.1002/1097-0142(19890401)63:7<1308::AID-CNCR2820630714>3.0.CO;2-Y
  18. Hughes MN, Llamas KJ, Yelland ME, Tripcony LB : Pituitary adenomas : Long-term results for radiotherapy alone and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 27 : 1035-1043, 1993 https://doi.org/10.1016/0360-3016(93)90520-6
  19. Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T, et al. : Gamma knife radiosurgery for pituitary adenomas. J Neurosurg (Suppl 3) 93 : 19-22, 2000 https://doi.org/10.3171/jns.2000.93.1.0019
  20. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, et al : Stereotactic radiosurgery for recurrent surgically treated acromegaly : comparison with fractionated radiotherapy. J Neurosurg 88 : 1002-1008, 1998 https://doi.org/10.3171/jns.1998.88.6.1002
  21. Laws ER Jr, Vance ML : Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 10 : 327-336, 1999
  22. Leber KA, Bergloff J, Pendl G : Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88 : 43-50, 1998 https://doi.org/10.3171/jns.1998.88.1.0043
  23. Linskey ME, Flickinger JC, Lunsford LD : Cranial nerve length predicts the risk of delayed facial and trigeminal neuropathies after acoustic tumor stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 25 : 227-233, 1993
  24. Mampalam TJ, Tyrrell JB, Wilson CB : Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 109 : 487-493, 1988
  25. Martinez R, Bravo G, Burzaco J, Rey G : Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Stereotact Funct Neurosurg 70 (Suppl 1) : 110-118, 1998 https://doi.org/10.1159/000056413
  26. McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB, Rhoton AL, et al : Radiotherapy for pituitary adenoma : Longterm outcome and sequelae. Int J Radiat Oncol Biol Phys 39 : 437-444, 1997 https://doi.org/10.1016/S0360-3016(97)00335-0
  27. Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D : Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas : experience in 88 patients. J Neurosurg 90 : 42-49 https://doi.org/10.3171/jns.1999.90.1.0042
  28. Ove R, kelman S, Amin PP, Chin LS : Preservation of visual fields after peri-sellar gamma-knife radiosurgery. Int J Cancer 90 : 343-350, 2000 https://doi.org/10.1002/1097-0215(20001220)90:6<343::AID-IJC6>3.0.CO;2-H
  29. Pan L, Zhang N, Wang EM, Wang BJ, Dai JZ, Cai PW : Gamma knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg (Suppl 3) 93 : 10-13, 2000
  30. Park YG, Chang JW, Kim EY, Chung SS : Gamma Knife surgery in pituitary microadenomas. Yonsei Med J 37 : 165-173, 1996
  31. Petrovich Z, Jozsef G, Yu C, Apuzzo MLJ : Radiotherapy and stereotactic radiosurgery for pituitary tumors. Neurosurg Clin N Am 14 : 147-166, 2003 https://doi.org/10.1016/S1042-3680(02)00031-1
  32. Pham CJ, Chang SD, Gibbs IC, Jones P, Heilbrun MP, Adler JR Jr : Preliminary visual field preservation after staged CyberKnife radiosurgery for perioptic lesions. Neurosurgery 54 : 799-810; discussion 810-812, 2004
  33. Rush S, Cooper PR : Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys 37 : 1031-1034, 1997
  34. Sheehan JM, Vance ML, Sheehan JP, Ellegala DB, Law ER Jr : Radiosurgery for Cushing disease after failed transsphenoidal surgery. J Neurosurg 93 : 738-742, 2000 https://doi.org/10.3171/jns.2000.93.5.0738
  35. Takakura K : Diagnosis of brain tumor. In : The committee of brain tumor registry of Japan (ed). General rules for clinical and pathological studies on brain tumors [in Japanese]. Tokyo : Kanehara Publishing Co., 2002
  36. Thoren MR, Rahn T, Guo WY, Werner S : Stereotactic radiosurgery with cobalt-60 gamma unit in the treatment of growth hormone producing pituitary tumors. Neurosurgery 29 : 663-668, 1991 https://doi.org/10.1227/00006123-199111000-00004
  37. Tran LM, Blount L, Horton D, Sadeghi A, Parker RG : Radiation therapy of pituitary tumors : results in 95 cases. Am J Clin Oncol 14 : 25-29, 1991 https://doi.org/10.1097/00000421-199102000-00005
  38. Tsagarakis S, Grossman A, Plowman PN, Jones AE, Touzel R, Rees LH, et al : Megavoltage pituitary irradiation in the management of prolactinomas : long-term follow-up. Clin Endocrinol (Oxf) 34 : 399-406, 1991 https://doi.org/10.1111/j.1365-2265.1991.tb00312.x
  39. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ : Radiation therapy for pituitary adenoma : Treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30 : 557-565, 1994
  40. Witt TC, Kondziolka D, Flickinger JC, Lunsford LD : Gamma Knife radiosurgery for pituitary tumors. Basel : Karger, 1998, Vol 14
  41. Wollesen F, Bendsen BB : Effect rates of different modalities for treatment of prolactin adenomas. Am J Med 78 : 114-122, 1985 https://doi.org/10.1016/0002-9343(85)90471-1
  42. Zierhut D, Flentije M, Adolph J, Erdmann J, Raue F, Wannenmacher M : External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33 : 307-314, 1995

Cited by

  1. Stereotactic Radiosurgery/Radiotherapy for Pituitary Adenomas: A Review of Recent Literature vol.50, pp.9, 2009, https://doi.org/10.2176/nmc.50.749
  2. Radiation treatment strategies for acromegaly vol.29, pp.4, 2009, https://doi.org/10.3171/2010.7.focus10124
  3. The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas vol.29, pp.4, 2009, https://doi.org/10.3171/2010.7.focus10159
  4. Recent advances in pituitary tumor management vol.18, pp.4, 2009, https://doi.org/10.1097/med.0b013e32834871f6
  5. Long-term Outcomes After Gamma Knife Stereotactic Radiosurgery for Nonfunctional Pituitary Adenomas vol.69, pp.6, 2009, https://doi.org/10.1227/neu.0b013e318222afed
  6. Surgery and Radiosurgery for Acromegaly: A Review of Indications, Operative Techniques, Outcomes, and Complications vol.2012, pp.None, 2009, https://doi.org/10.1155/2012/386401
  7. Comprehensive review of stereotactic radiosurgery for medically and surgically refractory pituitary adenomas vol.3, pp.suppl2, 2012, https://doi.org/10.4103/2152-7806.95419
  8. LINAC-radiosurgery for nonsecreting pituitary adenomas : Long-term results vol.188, pp.4, 2012, https://doi.org/10.1007/s00066-011-0052-5
  9. Hybrid Cyberknife/IMRT radiotherapy for peri-sellar tumors vol.2, pp.2, 2009, https://doi.org/10.1007/s13566-013-0092-9
  10. Characteristics of Acromegaly in Korea with a Literature Review vol.28, pp.3, 2009, https://doi.org/10.3803/enm.2013.28.3.164
  11. Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy : High local control and low toxicity in a pooled series vol.191, pp.6, 2015, https://doi.org/10.1007/s00066-014-0802-2
  12. Updates in outcomes of stereotactic radiation therapy in acromegaly vol.20, pp.1, 2009, https://doi.org/10.1007/s11102-016-0783-5
  13. Role of Cyber knife Radiosurgery in pituitary mass and improvement in growth hormone levels vol.9, pp.5, 2009, https://doi.org/10.15406/jcpcr.2018.09.00362
  14. CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center’s experience vol.138, pp.2, 2018, https://doi.org/10.1007/s11060-018-2793-9
  15. CyberKnife radiotherapy for orbital metastases: A single-center experience on 24 lesions vol.29, pp.1, 2009, https://doi.org/10.1177/1120672118761728